<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04943874</url>
  </required_header>
  <id_info>
    <org_study_id>2020-0994</org_study_id>
    <nct_id>NCT04943874</nct_id>
  </id_info>
  <brief_title>Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain</brief_title>
  <official_title>Feasibility and Acceptability of a Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain in Children and Adolescents After Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanessa Olbrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop and refine a technology based treatment protocol for preoperative education and&#xD;
      training and postoperative care in children and adolescents undergoing surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aim 1: Treatment protocol refinement</measure>
    <time_frame>Duration of study up to 30 days</time_frame>
    <description>Frequency of sessions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aim 1: Treatment protocol refinement</measure>
    <time_frame>Duration of study up to 30 days</time_frame>
    <description>Duration of sessions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aim 2: Feasibility of technology intervention in perioperative patients</measure>
    <time_frame>Pre-intervention</time_frame>
    <description>Rate of study recruitment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aim 1: Preoperative training protocol</measure>
    <time_frame>Up to two weeks pre-operatively</time_frame>
    <description>Frequency of preoperative training session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 1: Preoperative training protocol</measure>
    <time_frame>Up to two weeks pre-operatively</time_frame>
    <description>Duration of preoperative training session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 1: Post-operative session protocol</measure>
    <time_frame>Up to two week post surgery</time_frame>
    <description>Frequency of post-operative intervention session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 1: Post-operative session protocol</measure>
    <time_frame>Up to two weeks post surgery</time_frame>
    <description>Duration of post-operative intervention session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Rate of study enrollment/randomization</measure>
    <time_frame>Pre-intervention</time_frame>
    <description>Assessment of ability to enroll and randomize patients in pilot clinical trial</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Rate of study retention</measure>
    <time_frame>Duration of study up to 30 days</time_frame>
    <description>Assessment of ability to retain patients in pilot clinical trial</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Rate of treatment adherence</measure>
    <time_frame>Duration of study up to 30 days</time_frame>
    <description>Assessment of patient adherence to study protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Treatment-specific satisfaction</measure>
    <time_frame>Post intervention up to two weeks</time_frame>
    <description>Qualitative feedback from participants using questionnaire to assess intervention satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Treatment-specific satisfaction</measure>
    <time_frame>Post intervention up to two weeks</time_frame>
    <description>Qualitative feedback from participants using semi-structured interview to assess intervention satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on anxiety</measure>
    <time_frame>30 minutes after using technology</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on medication use</measure>
    <time_frame>Duration of hospital stay (48 - 96 hours)</time_frame>
    <description>Medications used will be collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on anxiety</measure>
    <time_frame>Before using technology</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on anxiety</measure>
    <time_frame>Immediately after using technology</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on pain</measure>
    <time_frame>Preoperatively (up to 168 hours)</time_frame>
    <description>Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on pain</measure>
    <time_frame>Before using technology</time_frame>
    <description>Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on pain</measure>
    <time_frame>Immediately after using technology</time_frame>
    <description>Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Effect of technology on pain</measure>
    <time_frame>30 minutes after using technology</time_frame>
    <description>Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 2: Self-Reported Outcomes</measure>
    <time_frame>Day of hospital discharge (Postoperatively 48-96 hours)</time_frame>
    <description>Semi-structured interview</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pain</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Pain, Acute</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Technology Based Intervention 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Technology Based Intervention 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Technology Based Intervention Group 1</intervention_name>
    <description>Participants will be blinded to the two specific groups. They will not be aware of the technology used in the group they are not assigned too.</description>
    <arm_group_label>Technology Based Intervention 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Technology Based Intervention Group 2</intervention_name>
    <description>Participants will be blinded to the two specific groups. They will not be aware of the technology used in the group they are not assigned too.</description>
    <arm_group_label>Technology Based Intervention 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 12 -18 years&#xD;
&#xD;
          -  Scheduled to undergo surgery anticipated to cause moderate to severe pain with&#xD;
             expected length of stay &gt; or = to 2 days&#xD;
&#xD;
          -  Able to read, understand and speak English&#xD;
&#xD;
          -  Patients requiring management by the Acute Pain Service&#xD;
&#xD;
          -  Possession of a mobile device/computer available for study participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Outside the age range (&lt; 12 or &gt; 18 years)&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
          -  History of significant developmental delay, uncontrolled psychiatric conditions&#xD;
             associated with hallucinations or delusions, or neurological conditions (especially&#xD;
             epilepsy and/or significant motion sickness/nausea/vomiting)&#xD;
&#xD;
          -  History of vertigo, dizziness, seizure disorder, and/or severe motion sickness&#xD;
&#xD;
          -  History of chronic pain&#xD;
&#xD;
          -  Are currently using opioids and or benzodiazepines for the management of pain&#xD;
&#xD;
          -  Are actively experiencing nausea or vomiting&#xD;
&#xD;
          -  Conditions that would preclude the application of the VR headset, such as craniofacial&#xD;
             abnormalities or surgeries of the head and neck&#xD;
&#xD;
          -  Previous participation in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vanessa Olbrecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa Olbrecht, MD</last_name>
    <phone>614-722-4142</phone>
    <email>vanessa.olbrecht@nationwidechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Rice-Weimer, RN</last_name>
    <phone>614-355-3142</phone>
    <email>julie.rice-weimer@nationwidechildrens.org</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Vanessa Olbrecht</investigator_full_name>
    <investigator_title>Vice Chair Quality Improvement and Development, Associate Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

